Bladder Cancer Information Center
Each year in the United States, more than 51,000 men and more than 17,000 women are diagnosed with bladder cancer. Thanks to improvements in treatment, bladder cancer patients are living longer than ever before. It is estimated that there are more than 500,000 bladder cancer survivors in the U.S. today.
Advances in surgery, chemotherapy, immunotherapy, and radiation therapy
have all contributed to improved bladder cancer survival. In addition, advances in supportive care have made bladder cancer treatment more tolerable, leading to improved quality of life.
Understanding bladder cancer treatment options, the role of different doctors specializing in the treatment of bladder cancer, and how and when to access new and innovative bladder cancer treatment options available through clinical trials is essential in order to achieve the best outcome from bladder cancer treatment.
The Cancer Consultants Bladder Cancer Information Center has been designed to help patients understand bladder cancer and bladder cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of bladder cancer.
Headline Bladder Cancer News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence
Chemotherapy plus radiation reduces risk of bladder cancer recurrence compared to radiation alone.
Study Compares Two Types of BCG for Bladder Cancer
One strain appears to be more effective than the other
Bladder Cancer Tips
Men, Fertility, and Cancer Men who confront a cancer diagnosis before beginning or completing their families...
Women, Fertility and Cancer Women who confront a cancer diagnosis before beginning or completing their families...
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Bladder Cancer Management
Inspiration, Hope & Resources
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Bladder Cancer Clinical Trials
E1804 – Phase II Trial of Sorafenib (BAY-43) (IND69896;NSC 724772) in Patients with Advanced Urothelial Cancer
A-1-08 – Phase II Single-arm, Single-Agent Multicenter, Adaptive 2-Stage Study to Evaluate the Efficacy, Safety and Pharmacokinetics of AZD4877 Administered Weekly in Patients with Recurrent Advanced Urothelial Cancer.
GU07 – A Phase II Trial Of Paclitaxel, Carboplatin, And Gemcitabine In The Treatment of Advanced Transitional Cell Carcinoma of The Urothelial Tract.
 |
 |
 |
 |
